TGF-8027
TGF-8027, or TGF-8-027, also known as N-[1-(2-hydroxyphenyl)ethyl]-2,5-dimethoxy-4-cyanophenethylamine, is a highly selective serotonin 5-HT 2A receptor agonist and putative serotonergic psychedelic of the phenethylamine, 2C, and 25-NB…
≈ 5 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
TGF-8027, or TGF-8-027, also known as N-[1-(2-hydroxyphenyl)ethyl]-2,5-dimethoxy-4-cyanophenethylamine, is a highly selective serotonin 5-HT 2A receptor agonist and putative serotonergic psychedelic of the phenethylamine, 2C, and 25-NB (NBOH) families. It is one of the most selective serotonin 5-HT 2A receptor agonists known and shows much greater selectivity than earlier agents like 25CN-NBOH, DMBMPP, and LPH-5.
The drug produces psychedelic-like effects in rodents and hence may be hallucinogenic in humans. TGF-8027 was first described in the literature in 2025.
Pharmacodynamics
TGF-8027 acts as a highly selective serotonin 5-HT 2A receptor full agonist. Its affinities (K i ) were 7.4 nM at the serotonin 5-HT 2A receptor, 390 nM at the serotonin 5-HT 2B receptor, and 1,100 nM at the serotonin 5-HT 2C receptor.
The drug's and values in terms of G q dissociation were 3.3 nM (91%) at the human serotonin 5-HT 2A receptor, 7,600 nM (45%) at the human serotonin 5-HT 2B receptor, and 160 nM (123%) at the human serotonin 5-HT 2C receptor. It was also assessed at these receptors with other assays.
In addition, TGF-8027 was screened at a large panel of other targets, including receptors and transporters, and showed relatively little affinity at these sites. With regard to selectivity for the human serotonin 5-HT 2A receptor over the human serotonin 5-HT 2C receptor, TGF-8027 showed 149-fold selectivity in terms of affinity, 48.5-fold selectivity in terms of G q dissociation, 84.5-fold selectivity in terms of calcium flux, and 2,450-fold selectivity in terms of IP1 accumulation.
It is far more selective as an agonist of the serotonin 5-HT 2A receptor over the serotonin 5-HT 2C receptor than previous selective serotonin 5-HT 2A receptor agonists such as 25CN-NBOH, DMBMPP, and rac-LPH-5 (fold selectivity for G q dissociation in the same study of 10.0, 13.5, and 4.4, respectively). Previous research had not rigorously assessed the selectivity of these earlier compounds via employment of multiple selectivity assays.
TGF-8027 was less selective for the mouse serotonin 5-HT 2A receptor over the mouse serotonin 5-HT 2C receptor, but still showed about 15-fold selectivity for the former over the latter in terms of G q dissociation. In accordance with its serotonin 5-HT 2A receptor activation, the drug robustly induces the head-twitch response, a behavioral proxy of psychedelic effects, in mice.
As such, it would be expected to produce psychedelic effects in humans. The compound is a racemic mixture of (+)- and (–)-enantiomers, with the (–)-enantiomer being a more potent serotonin 5-HT 2A receptor agonist but the (+)-enantiomer being more selective for activation of the serotonin 5-HT 2A receptor over the serotonin 5-HT 2C receptor.
Chemistry
TGF-8027, also known as N-[1-(2-hydroxyphenyl)ethyl]-2,5-dimethoxy-4-cyanophenethylamine, is a substituted phenethylamine and a 2C and 25-NB (NBOH) derivative. It is specifically the derivative of 25CN-NBOH in which the benzyl group has been α-methylated. The compound is a racemic mixture of (+)- and (–)-enantiomers.
A series of other analogues of TGF-8027 have also been reported, some of which show further improved serotonin 5-HT 2A receptor selectivity relative to TGF-8027 itself.
History
TGF-8027 was first described in the scientific literature by John McCorvy's lab and colleagues in 2025. The group also included Adam Halberstadt. The serotonin 5-HT 2A and 5-HT 2C receptors show considerable homology, which has made development of selective serotonin 5-HT 2A receptor agonists difficult.
TGF-8027 was discovered via a rational structure-guided design that took advantage of an identified single-residue difference between the serotonin 5-HT 2A receptor and the serotonin 5-HT 2C receptor in transmembrane 2 (TM2) of the extended binding pocket. The group also reported a series of other selective serotonin 5-HT 2A receptor agonists in addition to TGF-8027, some of which showed even further improved selectivity.
TGF-8027 was selected for more in-depth characterization over other compounds, for instance in the head-twitch response assay, because it showed among the highest selectivity and potency at the mouse serotonin 5-HT 2A receptor in addition to the human serotonin 5-HT 2A receptor.
Canada
TGF-8027 may be a controlled substance in Canada under phenethylamine blanket-ban language.
United States
TGF-8027 is not an explicitly controlled substance in the United States. However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.
See also
25-NB 25CN-NBOH 2C-CN DOCN
External links
TGF-8027 - Isomer Design
Text derived from https://en.wikipedia.org/w/index.php?oldid=1338424613 under CC BY-SA 4.0; modifications have been made.